In clinical trials, participants who used semaglutide GLP-1, the active ingredient in Ozempic, for weight management experienced significant weight loss within a relatively short period
Susan Spratt, an endocrinologist and the senior medical director for the Population Health Management Office at Duke Health in North Carolina, advised that patients prescribed GLP-1 drugs should be counseled about starting the lowest dose and gradually increasing it, waiting at least four to six weeks before they escalate to the next dose
Continue reading to learn more about what we know about Ozempic and pregnancy
This extended presence influences clinical decisions around surgery, switching medications, and discontinuation strategies
Mace Scott, Chronos Body Health & Wellness Chronos patients dont just receive medication
Some researchers hypothesize that the increased energy expenditure from glucagon activation means less of the caloric deficit needs to come from dietary restriction, which may be less catabolic to muscle tissue
/assets/images/provider/photos/2800172.png)
